Shingo Hatakeyama

3.7k total citations
188 papers, 2.6k citations indexed

About

Shingo Hatakeyama is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Shingo Hatakeyama has authored 188 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pulmonary and Respiratory Medicine, 71 papers in Surgery and 38 papers in Molecular Biology. Recurrent topics in Shingo Hatakeyama's work include Bladder and Urothelial Cancer Treatments (52 papers), Urinary and Genital Oncology Studies (35 papers) and Prostate Cancer Treatment and Research (34 papers). Shingo Hatakeyama is often cited by papers focused on Bladder and Urothelial Cancer Treatments (52 papers), Urinary and Genital Oncology Studies (35 papers) and Prostate Cancer Treatment and Research (34 papers). Shingo Hatakeyama collaborates with scholars based in Japan, United States and Taiwan. Shingo Hatakeyama's co-authors include Chikara Οhyama, Yasuhiro Hashimoto, Takuya Koie, Takahiro Yoneyama, Tohru Yoneyama, Hayato Yamamoto, Yuki Tobisawa, Minoru Fukuda, Tomonori Habuchi and Teppei Okamoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Shingo Hatakeyama

174 papers receiving 2.6k citations

Peers

Countries citing papers authored by Shingo Hatakeyama

Since Specialization

Citations

This map shows the geographic impact of Shingo Hatakeyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Hatakeyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Hatakeyama more than expected).

Fields of papers citing papers by Shingo Hatakeyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Hatakeyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Hatakeyama. The network helps show where Shingo Hatakeyama may publish in the future.

Co-authorship network of co-authors of Shingo Hatakeyama

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Hatakeyama. A scholar is included among the top collaborators of Shingo Hatakeyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Hatakeyama. Shingo Hatakeyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Benefits of Preemptive Living Kidney Transplantation: Reduced Rates of Cerebro‐Cardiovascular Events and Neoplasm Development 2025 ·International Journal of Urology ·(unknown), (unknown), Mitsuru Saito, (unknown), Shinya Maita, Reiichi Murakami, (unknown), (unknown), Hirofumi Tomita, Hisao Saitoh, Norihiko Tsuchiya, Tomonori Habuchi, Wataru Obara, Chikara Οhyama, Shingo Hatakeyama	0
2	Analytical and Real‐World Clinical Characterization of S2,3PSA% Test in MRI Fusion Targeted Prostate Biopsy Population 2025 ·The Prostate ·Yuki Miura, Tohru Yoneyama, Hayato Yamamoto, Hiromu Suzuki, Toshimichi Otsubo, (unknown), (unknown), Shintaro Goto, Teppei Okamoto, Naoki Fujita, (unknown), Tadashi Yoshizawa, Shingo Kakeda, Shingo Hatakeyama, Chikara Οhyama	4
3	The Effects of the Blood‐Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies 2025 ·The Prostate ·(unknown), (unknown), Tohru Yoneyama, (unknown), (unknown), (unknown), Yuki Miura, Akio Yoneyama, Hiroyuki Sato, (unknown), (unknown), (unknown), Naoki Fujita, Teppei Okamoto, (unknown), Shingo Kakeda, Chikara Οhyama, Shingo Hatakeyama	3
4	Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter study 2024 ·The Prostate ·Takafumi Yanagisawa, Wataru Fukuokaya, Shingo Hatakeyama, Shintaro Narita, (unknown), (unknown), (unknown), Fumihiko Urabe, (unknown), Kojiro Tashiro, Kosuke Iwatani, (unknown), Tomonori Habuchi, Takahiro Kimura	4
5	Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study 2023 ·The World Journal of Men s Health ·Naoki Fujita, Masaki Momota, (unknown), Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Οhyama	1
6	Association between Advanced Glycation End-Products, Carotenoids, and Severe Erectile Dysfunction 2023 ·The World Journal of Men s Health ·Naoki Fujita, (unknown), (unknown), Hiroyuki Suganuma, (unknown), Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tatsuya Mikami, Ken Itoh, Chikara Οhyama	7
7	Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi-institutional retrospective study 2022 ·International Journal of Clinical Oncology ·Renpei Kato, Sei Naito, Kazuyuki Numakura, Shingo Hatakeyama, Tomoyuki Koguchi, Takahiro Kojima, Yoshihide Kawasaki, Shuya Kandori, Sadafumi Kawamura, Yoichi Arai, Akihiro Ito, Hiroyuki Nishiyama, Yoshiyuki Kojima, Chikara Οhyama, Tomonori Habuchi, Norihiko Tsuchiya, Wataru Obara	8
8	Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study 2022 ·The World Journal of Men s Health ·Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Οhyama	1
9	Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high‐risk non‐muscle‐invasive bladder cancer who receive adjuvant induction bacillus Calmette‐Guérin therapy 2022 ·International Journal of Urology ·Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Οhyama	1
10	Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer 2021 ·British Journal of Cancer ·Koji Hatano, Tohru Yoneyama, Shingo Hatakeyama, Eisuke Tomiyama, (unknown), (unknown), Kazuhiro Yoshimura, Eiji Miyoshi, Hirotsugu Uemura, Chikara Οhyama, Norio Nonomura, Kazutoshi Fujita	17
11	Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study 2021 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Shingo Hatakeyama, Hideo Kawaguchi, Yoshiomi Hatayama, Yusuke Ishibashi, (unknown), Daisuke Noro, Toshikazu Tanaka, Hiroyuki Ito, (unknown), Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Masahiko Aoki, Chikara Οhyama	11
12	N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas 2021 ·Cancer Medicine ·(unknown), Tohru Yoneyama, Toshikazu Tanaka, Daisuke Noro, Yuki Tobisawa, Hayato Yamamoto, (unknown), Shingo Hatakeyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuko Kakizaki, Shigeyuki Nakaji, Chikara Οhyama	6
13	Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: A multicenter study 2020 ·European Urology Open Science ·Yuka Kubota, Shingo Hatakeyama, (unknown), Hayato Yamamoto, (unknown), (unknown), (unknown), (unknown), Kiyotsugu Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Chikara Οhyama	2
14	The Impact of Glycosylation of Osteopontin on Urinary Stone Formation 2019 ·International Journal of Molecular Sciences ·(unknown), Tohru Yoneyama, Daisuke Noro, Yuki Tobisawa, Shingo Hatakeyama, (unknown), Hayato Yamamoto, Atsushi Imai, Hiromichi Iwamura, (unknown), (unknown), Jun Ito, Yasuhiro Kaiho, Takahiro Yoneyama, Yasuhiro Hashimoto, Makoto Sato, Chikara Οhyama	15
15	Clinical significance of the LacdiNAc‐glycosylated prostate‐specific antigen assay for prostate cancer detection 2019 ·Cancer Science ·Tohru Yoneyama, Yuki Tobisawa, (unknown), Takatoshi Kaya, Shingo Hatakeyama, Kazuyuki Mori, (unknown), (unknown), Koji Mitsuzuka, Wilhelmina Duivenvoorden, Jehonathan H. Pinthus, Yasuhiro Hashimoto, Akihiro Ito, Takuya Koie, (unknown), Robert A. Gardiner, Chikara Οhyama	25
16	Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan 2018 ·British Journal of Urology ·(unknown), Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, (unknown), (unknown), (unknown), Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Οhyama	27
17	An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis 2017 ·International Journal of Molecular Sciences ·(unknown), Tohru Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, (unknown), Kenji Nakamura, Shintaro Narita, Koji Mitsuzuka, Wilhelmina Duivenvoorden, Jehonathan H. Pinthus, Yasuhiro Hashimoto, Takuya Koie, Tomonori Habuchi, Yoichi Arai, Chikara Οhyama	43
18	Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant 2017 ·International Journal of Molecular Sciences ·Daisuke Noro, Tohru Yoneyama, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin‐Ichiro Nishimura, Hideo Sasaki, Mitsuru Saito, Hiroshi Harada, Tatsuya Chikaraishi, Hideki Ishida, Kazunari Tanabe, Shigeru Satoh, Chikara Οhyama	10
19	Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer 2017 ·International Journal of Molecular Sciences ·(unknown), Yuki Tobisawa, Takatoshi Kaya, (unknown), Shingo Hatakeyama, Kazuyuki Mori, Yasuhiro Hashimoto, Takuya Koie, (unknown), Chikara Οhyama, Tohru Yoneyama	33
20	Tumor suppressor function of laminin-binding α-dystroglycan requires a distinct β3- N -acetylglucosaminyltransferase 2009 ·Proceedings of the National Academy of Sciences ·Xingfeng Bao, Motohiro Kobayashi, Shingo Hatakeyama, Kiyohiko Angata, Donald Gullberg, Jun Nakayama, Michiko N. Fukuda, Minoru Fukuda	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact